Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (Hdc-Asct) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred? Meeting Abstract


Authors: Omuro, A.; Abrey, L.; Raizer, J.; Paleologos, N.; Forsyth, P.; DeAngelis, L.; Kaley, T.; Louis, D.; Cairncross, J. G.; Matasar, M.; Mehta, J.; Grimm, S.; Moskowitz, C.; Sauter, C.
Abstract Title: Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (Hdc-Asct) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred?
Meeting Title: 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO)/18th Annual Meeting of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 15
Issue: Suppl. 3
Meeting Dates: 2013 Nov 21-24
Meeting Location: San Francisco, CA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2013-11-01
Start Page: iii125
Language: English
ACCESSION: WOS:000327456200500
PROVIDER: wos
DOI: 10.1093/neuonc/not182
PMCID: PMC3823897
Notes: Meeting Abstract: NO-108 -- Source: Wos
Altmetric Score
MSK Authors
  1. Craig Moskowitz
    374 Moskowitz
  2. Antonio Marcilio Padula Omuro
    177 Omuro
  3. Thomas Kaley
    89 Kaley
  4. Craig Steven Sauter
    166 Sauter
  5. Lauren E Abrey
    272 Abrey
  6. Matthew J Matasar
    121 Matasar